Japanese Real Estate Stock News

Kewpie (TSE:2809) has reported Q2 2026 revenue of ¥136.9 billion and basic EPS of ¥57.08, giving investors fresh numbers to weigh against a year in which trailing 12 month EPS stands at ¥181.05 on revenue of ¥523.2 billion. Over recent quarters the company has seen revenue move from ¥131.8 billion in Q2 2025 to ¥136.9 billion in Q2 2026, while quarterly EPS has shifted from ¥43.35 to ¥57.08. This sets up a results season where net margin trends are likely to be front and center for investors...

CREEK & RIVER (TSE:4763) opened Q1 2027 with revenue of ¥17.0 billion and basic EPS of ¥70.18, setting the tone for a quarter where profitability stayed front and center. Over recent quarters the company has seen revenue move from ¥13.8 billion and EPS of ¥43.20 in Q1 2026 to ¥17.0 billion and EPS of ¥70.18 in Q1 2027, alongside trailing 12 month EPS of ¥218.09, which frames the latest print against a period of strong earnings growth. With trailing net margin now higher than a year ago and...

NOMURA (TSE:9716) opened Q1 2027 with revenue of ¥35.7 billion and basic EPS of ¥12.77, setting the tone for a quarter where the top line and earnings metrics will be closely watched against a mixed recent track record. Over the past five reported quarters, revenue has moved between ¥39.7 billion and ¥56.0 billion while basic EPS ranged from ¥12.71 to ¥40.54, giving investors a clear view of how the income statement has shifted through the cycle and what that might mean for margins now. With...

Custom Market Insights has released a new forecast for the global lithium ion battery market, highlighting Panasonic Holdings (TSE:6752) as a key participant in projected demand tied to energy storage and electric vehicles. See our latest analysis for Panasonic Holdings. At a share price of ¥4,480.0, Panasonic Holdings has seen a 19.28% 1 month share price return and a 56.59% 3 month share price return, contributing to a 1 year total shareholder return of 215.52%. This reflects strong recent...

Board meeting puts Mitsubishi Materials’ financing plans in focus Mitsubishi Materials (TSE:5711) has called a board meeting for 8 July 2026 to review issuing zero coupon convertible bonds maturing in 2030 and 2032, a financing step that could matter for shareholders. See our latest analysis for Mitsubishi Materials. The board meeting takes place at a time when Mitsubishi Materials’ share price has been under pressure in recent months, with a 7 day share price return of down 10.27% and a 90...

Pfizer and Astellas Pharma recently announced that the U.S. FDA approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda as both neoadjuvant and adjuvant treatment for adult patients with muscle-invasive bladder cancer, regardless of cisplatin eligibility, based on positive Phase 3 EV-304 trial data versus standard gemcitabine-cisplatin chemotherapy. This marks the first platinum-free regimen approved for all muscle-invasive bladder cancer patients, materially expanding the clinical and...

DENSO stock: why a battery passport trial matters for investors DENSO (TSE:6902) is in focus after working with TÜV Rheinland Japan and AESC Group on a battery passport validation that aligns with EU Battery Regulation requirements for energy storage systems. The project used real data from AESC's energy storage business and confirmed that DENSO's battery passport service can support traceability, data security and regulatory compliance for products headed to Europe. See our latest analysis...

ABC-MartInc (TSE:2670) drew investor attention after reporting June 2026 sales, with all stores and existing stores both showing a 6.6% decline compared with growth just over 6% a year earlier. See our latest analysis for ABC-MartInc. At a share price of ¥2,620.5, ABC-MartInc has seen its short term momentum soften, with the 7 day share price return down 6.41% and the 30 day share price return down 4.81%, while the 5 year total shareholder return of 46.43% points to a stronger longer term...

The record US$26.5b Nasdaq listing of SK Hynix has put AI semiconductor stocks firmly back in the spotlight, with investors watching how fresh capital for high bandwidth memory and AI chip production might ripple through the sector. With bookbuilding reportedly 7x oversubscribed and expectations that the new ADR could influence how similar businesses are valued, this news is hard to ignore if you follow AI hardware. Below, you will see 3 stocks from our AI Semiconductor Stocks screener that...

Nihon Dengi Co., Ltd. ( TSE:1723 ), might not be a large cap stock, but it saw significant share price movement during...

Takara (TSE:7921) has wrapped up FY 2026 with fourth quarter revenue of ¥8.8 billion and basic EPS of ¥131.69, capping a year in which trailing twelve month revenue was ¥31.2 billion and EPS reached ¥261.92. Over recent quarters, revenue has ranged from ¥6.3 billion to ¥9.1 billion, while quarterly EPS has moved between ¥11.48 and ¥182.98, giving investors a clear view of how earnings power has shifted across the year. With a current net margin of 10.9% versus 13.7% a year earlier, the focus...

In early July 2026, Kasumigaseki Capital Co., Ltd. issued consolidated earnings guidance for the fiscal year ending August 31, 2026, forecasting net sales of ¥150,000 million, operating profit of ¥26,500 million, profit attributable to owners of parent of ¥16,500 million, and basic earnings per share of ¥672.42. At the same July 3, 2026 board meeting, the company also considered changes to its shareholder benefit program, signaling potential adjustments to how returns are structured for...

ROHM Semiconductor recently launched a new lineup of 600V Super Junction MOSFETs, the R60xxXNx and PrestoMOS R60xxWNx series, now in mass production and aimed at high-efficiency, space-saving power supplies for AI servers, data centers, and industrial equipment. The addition of compact DFN8080-5L and TOLL surface-mount packages with common footprints could make ROHM’s devices easier drop-in options for power designers seeking multi-sourcing flexibility and improved thermal performance. We’ll...

Sharp (TSE:6753) is drawing new attention after launching its first health-focused smartwatch, the Karada Mate Watch. The device uses HEALBE’s FLOW technology to automatically estimate calorie intake, hydration, and other physiological metrics. See our latest analysis for Sharp. Despite the Karada Mate Watch signalling a new push into digital health wearables, Sharp’s share price return tells a mixed story, with the stock down 18.75% year to date and up 6.9% over 90 days, while the 1 year...

Japan’s consumer goods and retail giants are sitting at the crossroads of two powerful forces: potential policy shifts from the Bank of Japan and global demand tied to AI and electronics. With rates holding at 1% for now and inflation pressures still on the BOJ’s radar, pricing power, cost control, and exposure to import costs all matter more for Japanese Consumer Goods and Retail stocks. This article explains how that backdrop connects to our screener and highlights 3 stocks that appear...

Ajinomoto Co., Inc. and the University of Tokyo recently reported that their jointly developed ANPS-Day system can assess a full day’s diet quality using biomarkers from healthy Japanese adults, marking a Japan-first link between real-world dietary data and 24-hour urine collection results. This scientific validation strengthens Ajinomoto’s position in health-oriented food technologies, potentially enhancing the credibility and differentiation of its nutrition-focused products and...

In July 2026, Custom Market Insights published a report projecting the global lithium-ion battery market to reach about US$468.50 billion by 2035, with Panasonic Holdings highlighted among the key industry participants benefiting from government-backed energy storage and electric vehicle demand. The report also points to Asia Pacific’s current leadership and very large expected growth in North America, underscoring how regional policy support could be especially important for manufacturers...

In recent weeks, global markets have shown mixed performances, with major U.S. indices like the Nasdaq Composite and S&P 500 advancing, while small-cap focused indices such as the Russell 2000 have seen declines amid a cooling labor market and subdued consumer confidence. As investors navigate these complex conditions, identifying promising small-cap stocks requires focusing on companies that demonstrate resilience through strong fundamentals and potential for growth in niche markets.

As global markets navigate mixed signals from economic data and sector-specific performances, investors are paying close attention to dividend stocks as a potential source of stability amid uncertainty. In this environment, a good dividend stock is often characterized by consistent payouts and strong fundamentals, offering investors the potential for steady income even when broader market conditions are volatile.

Recruit Holdings (TSE:6098) is back in focus after completing a share buyback tranche, repurchasing 7,063,300 shares for ¥52,398.22 million, as analysts spotlight its earnings growth potential. See our latest analysis for Recruit Holdings. The recent buyback news comes on top of a strong run in Recruit Holdings' share price, with a 30 day share price return of 11.8% and a 90 day share price return of 75.7%, while the 1 year total shareholder return of 49.76% and 3 year total shareholder...

CG Semi Private Limited, a joint venture between CG Power and Industrial Solutions, Renesas Electronics Corporation, and Stars Microelectronics, has begun commercial production at its G1 Outsourced Semiconductor Assembly and Test facility in Sanand, which was inaugurated in August 2025 and is designed for up to 300 million units per year. This launch marks a meaningful expansion of outsourced assembly and test capacity backed by over ₹76.00 billion of planned investment across two...

It's been a mediocre week for NEXTAGE Co., Ltd. ( TSE:3186 ) shareholders, with the stock dropping 11% to JP¥3,605 in...

The recent earnings posted by Daido Steel Co., Ltd. ( TSE:5471 ) were solid, but the stock didn't move as much as we...

In recent trading, Ono Pharmaceutical reported progress across its oncology and specialty medicine portfolio, including regulatory advances for Opdivo, expanded development of Velexbru, positive mid-stage data for ONO-4578 and ONO-2808, and a regulatory filing for Qinlock in Japan. These developments, alongside the launch of newer products like Romvimza and a broader rare disease and cancer portfolio, highlight Ono’s effort to diversify revenue sources beyond a single blockbuster...